Related Experiment Video
Updated: Jun 21, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
The prevalence of multiple sclerosis in the Middle East
Jasem Al-Hashel1, Aaron D Besterman, Christina Wolfson
1Department of Neurology and Neurosurgery, McGill University, Montreal, Que., Canada.
Background:
The prevalence of multiple sclerosis (MS) in the Middle East has been reported to be low to medium.
Methods:
To verify this assertion we conducted a review of published data on the occurrence of MS in the Middle East.
Results:
Fourteen studies reporting on the prevalence of MS in the Middle East were initially identified, 5 of which were excluded due to inadequate data or serious methodological limitations. The data from the 9 included studies suggested that the prevalence of MS may vary widely within the Middle East, from low to high. However, these 9 studies were inconsistent in case ascertainment, inclusion criteria and methods of prevalence calculation, and most did not include age/sex standardization.
Conclusion:
Methodological inconsistencies among studies make it difficult to be confident in drawing conclusions about the prevalence of MS in the Middle East. Nevertheless, there is little evidence to support the assertion that the prevalence of MS in the Middle East is low to medium. Rather, the prevalence of MS in the Middle East may range from low to high, depending on the specific population and environment of study. However, to confirm these findings, further epidemiological research is needed.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Multiple Sclerosis l: Introduction
Myasthenia Gravis ll: Pathophysiology

